Clinical Trial Update: Haploidentical HCT for Severe Aplastic Anemia [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 clinical trial evaluating haploidentical hematopoietic cell transplantation for severe aplastic anemia, currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Bone Marrow Failure Syndrome

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Aplastic Anemia, Bone Marrow Failure Syndrome | Phase 2 | Status: RECRUITING